Hydrochlorothiazide Capsule
Product Images NDC 65862-113

2 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 65862-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))
Label for Hydrochlorothiazide Capsules USP 12.5 mg by Aurobindo Pharma Limited, containing 100 capsules. The label includes storage instructions, dosage referencing the package insert, and distributor information for Aurobindo Pharma USA, Inc. The label also notes the NDC 65862-113-01 and includes a barcode.*
FDA Label Image

Chemical Structure (Hyctz Str)

Chemical Structure (Hyctz Str)
Chemical structure of Hydrochlorothiazide, showing its molecular arrangement including sulfonamide groups, chlorine, and nitrogen atoms in a benzothiadiazine ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.